Read the latest news, events and projects from our infection prevention and control programme. No images? Click here Hakihea| December 2024Kia ora and welcome to the latest newsletter from the infection prevention and control (IPC) team at Te Tāhū Hauora Health Quality & Safety Commission. In this edition - the WHO has published its second global report on IPC, 2 g vials of cefazolin are now available through Pharmac, check out our latest HA-SAB dashboard update, and more! IPC team updatesThe IPC team members are – Nikki Grae (senior manager), Tanya Jackways and Sue Atkins (IPC specialists) Marie Talbot (programme coordinator), Harini Srinivasan and David Waddell (data analysts) and our two clinical leads, Dr Sally Roberts and Dr Arthur Morris. You can email us at ipc@hqsc.govt.nz. Transition to Te Whatu Ora The burden of healthcare-associated infections in New ZealandThe data from the national point prevalence survey (PPS) conducted in 2021 has now been used to calculate the annual economic burden of HAIs in terms of cost, deaths and disability. These findings are detailed in the paper published in the Infection Control & Hospital Epidemiology journal, ‘The burden of healthcare-associated infections in New Zealand public hospitals 2021’. The analysis shows that the burden of HAIs is greater than many other health conditions and types of injury, for example, the HAI burden is greater than that due to road crashes. Here is a summary of the findings: WHO Global report on infection prevention and controlThis second global report on IPC provides updated evidence on the harm caused to patients and health workers by HAIs and AMR and presents an updated global analysis of the implementation of IPC programmes at the national and health care facility levels across all WHO regions. World Antimicrobial Awareness Week 2024 (WAAW), 18-24 NovemberThe week focused on raising awareness and understanding and promoting best practices to reduce the emergence and spread of drug-resistant infections. The theme was “Educate. Advocate. Act now.” New product 2 g cefazolinDid you know that 2 g vials of cefazolin, the recommended dose for adult surgical prophylaxis, are now available to order through the Pharmac schedule? Currently most adults needing cefazolin as prophylaxis receive a 2 g dose (3 g if >120 kg). As only 1 g vials have been available this has meant reconstituting two vials for each case. Please let your surgical and anaesthetic leads know so they can obtain 2 g vials for your procedures. Hand Hygiene New ZealandCompliance data Jul-Oct 2024 You can find district and overall private surgical hospital results for the Jul-Oct 2024 survey period on our dashboard. Surveillance updatesHealthcare-associated Staphylococcus aureus bacteraemia dashboard An electronic Healthcare-associated Staphylococcus aureus bacteraemia (HA-SAB) dashboard has now been published. The dashboard will be updated each quarter. Contact your IPC team for a link to the dashboard. 2-year Healthcare-associated Staphylococcus aureus bacteraemia surveillance analysis We published the first 12 months of HA-SAB surveillance (July 2022 to June 2023) results on our website, and we have now completed a 2-year analysis (July 2022 to June 2024). Australasian College for Infection Prevention and Control ConferenceIt was great to see so many from New Zealand at the conference in Melbourne in November. The theme was ‘Succession, sustainability, and the advancement of infection prevention and control’. Sue Atkins, Jo Stodart and Angie Foster all presented well and shone the IPC NZ flag for us. Important dates
Please note: Te Tāhū Hauora will be closed from 5pm Friday 20 December 2024, re-opening on 06 January 2025. Get in touchHHNZ questions, requests, information: hhnz@hqsc.govt.nz SSIIP questions, data-related enquiries: ssiip@hqsc.govt.nz General IPC questions, requests, information: ipc@hqsc.govt.nz Best wishes for a safe and happy holiday period from all of us in the IPC TeamThis newsletter isn’t designed to be forwarded like a regular email. If you’d like to share it, please use the ‘Forward’ button below – this will open a form where you can enter the relevant contact information. This information is not stored by us and is only used to forward the newsletter. |